- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03908931
Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results
March 16, 2026 updated by: Nicolas Pujol, Versailles Hospital
The purpose of this study is to evaluate the clinical results and MRI imaging of autologous cartilage reconstructions or collagen matrix of the knee.
There is currently little data in the literature on clinical outcomes and imaging of this type of lesion.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laure Morisset
- Phone Number: +33139239785
- Email: lmorisset@ch-versailles.fr
Study Contact Backup
- Name: Nicolas PUJOL
- Phone Number: +33139639565
- Email: npujol@ch-versailles.fr
Study Locations
-
-
-
Le Chesnay, France
- Recruiting
- CH de Versailles
-
Contact:
- Pujol
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- cartilaginous reconstruction by autologous transplant or collagenous chondro-inducing knee matrix
- > 18 years
Exclusion Criteria:
- Other cartilaginous reconstruction techniques,
- other than knee joint
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MRI
|
Follow up of osteochondral surgery by MRI and clinical examination
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Postoperative knee function assessed by clinical examination
Time Frame: 2 years post surgery
|
2 years post surgery
|
|
Postoperative knee function assessed by scores
Time Frame: 2 years post surgery
|
2 years post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2019
Primary Completion (Actual)
April 1, 2019
Study Completion (Estimated)
June 1, 2035
Study Registration Dates
First Submitted
April 5, 2019
First Submitted That Met QC Criteria
April 8, 2019
First Posted (Actual)
April 9, 2019
Study Record Updates
Last Update Posted (Actual)
March 17, 2026
Last Update Submitted That Met QC Criteria
March 16, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- P19/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteochondral Defect
-
AlloSourceRecruitingOsteochondral DefectUnited States
-
TBF Genie TissulaireTerminated
-
Stefano ZaffagniniActive, not recruitingOsteochondral DefectItaly
-
Peking University Third HospitalEnrolling by invitationOsteochondral; DefectChina
-
Epibone, Inc.MCRANot yet recruitingChondral Defect | Osteochondral Defect
-
Jordi Villalba ModolUnknownChondral Defect | Osteochondral DefectSpain
-
Episurf Medical Inc.RecruitingOsteochondral DefectGermany, Sweden
-
Collagen SolutionsCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Banc de Sang i TeixitsRecruitingOsteochondral DefectSpain
-
Medical University of ViennaSurgebright GmbhRecruitingOsteochondral DefectAustria
Clinical Trials on MRI
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
University of EdinburghCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupUnknownBreast Cancer | BIRADS 3 | BIRADS 4 | BIRADS 5United States
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Assistance Publique Hopitaux De MarseilleCompletedAmyotrophic Lateral SclerosisFrance
-
Medical University of ViennaCompletedBrachial Plexus Neuropathies | Traumatic Brachial Plexus Lesion | Bionic Hand ReconstructionAustria